Researcher.Life Logo

Pharmacogenomics and Personalized Medicine : Impact Factor & More

eISSN: 1178-7066pISSN: 1178-7066
JournalOpen Access

Key Metrics

CiteScore
3
Eigenfactor
0.001 - 0.005
Impact Factor
< 5
SJR
Q3Pharmacology
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Pharmacogenomics and Personalized Medicine

Pharmacogenomics and Personalized Medicine Journal Specifications

Indexed in the following public directories

  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher Dove Medical Press
Language English
Frequency Continuous publication
Article Processing ChargesUSD 2836
Publication Time16
Editorial Review ProcessBlind peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 16
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessBlind peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC
OA statementVisit website
View less

Planning to publish in Pharmacogenomics and Personalized Medicine ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Pharmacogenomics and Personalized Medicine

Construction and Validation of Multi-Omics Predictive Models for Colorectal Cancer Using Machine-Learning Approaches
  • 2 Apr 2026
  • Pharmacogenomics and Personalized Medicine
NAT2 Acetylation Phenotypes in India: A Narrative Review of Personalized TB Therapy
  • 10 Mar 2026
  • Pharmacogenomics and Personalized Medicine
Massive Hepatocellular Carcinoma with Insufficient Future Liver Remnant Achieved Complete Response After Two-Stage Hepatectomy Combined with Hepatic Arterial Infusion Chemotherapy and Lenvatinib-sintilimab: A Case Report.
  • 1 Jan 2026
  • Pharmacogenomics and personalized medicine
Post-Translational Modifications of Histones and Non-Histones in Liver Disease and Traditional Chinese Medicine Treatment: A Narrative Review.
  • 1 Jan 2026
  • Pharmacogenomics and personalized medicine
Clinical Outcomes of Osimertinib Combined with Platinum-Based Chemotherapy in EGFR-Mutant Non-Small Cell Lung Cancer: A Retrospective Study.
  • 1 Jan 2026
  • Pharmacogenomics and personalized medicine
Bioinformatic Identification and Preliminary Validation of TP53, TGFB1, and NFE2L2 as Potential Ferroptosis-Related Regulators in Pancreatic Adenocarcinoma.
  • 1 Jan 2026
  • Pharmacogenomics and personalized medicine
Construction and Validation of Multi-Omics Predictive Models for Colorectal Cancer Using Machine-Learning Approaches
  • 2 Apr 2026
  • Pharmacogenomics and Personalized Medicine
NAT2 Acetylation Phenotypes in India: A Narrative Review of Personalized TB Therapy
  • 10 Mar 2026
  • Pharmacogenomics and Personalized Medicine
Massive Hepatocellular Carcinoma with Insufficient Future Liver Remnant Achieved Complete Response After Two-Stage Hepatectomy Combined with Hepatic Arterial Infusion Chemotherapy and Lenvatinib-sintilimab: A Case Report.
  • 1 Jan 2026
  • Pharmacogenomics and personalized medicine
Post-Translational Modifications of Histones and Non-Histones in Liver Disease and Traditional Chinese Medicine Treatment: A Narrative Review.
  • 1 Jan 2026
  • Pharmacogenomics and personalized medicine
Clinical Outcomes of Osimertinib Combined with Platinum-Based Chemotherapy in EGFR-Mutant Non-Small Cell Lung Cancer: A Retrospective Study.
  • 1 Jan 2026
  • Pharmacogenomics and personalized medicine
Bioinformatic Identification and Preliminary Validation of TP53, TGFB1, and NFE2L2 as Potential Ferroptosis-Related Regulators in Pancreatic Adenocarcinoma.
  • 1 Jan 2026
  • Pharmacogenomics and personalized medicine

FAQs on Pharmacogenomics and Personalized Medicine